Lloyd Mackenzie
2018
In 2018, Lloyd Mackenzie earned a total compensation of $1.9M as Former Chief Operating Officer at Aquinox Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $127,750 |
|---|---|
| Option Awards | $1,152,576 |
| Salary | $380,442 |
| Other | $276,671 |
| Total | $1,937,439 |
Mackenzie received $1.2M in option awards, accounting for 59% of the total pay in 2018.
Mackenzie also received $127.8K in non-equity incentive plan, $380.4K in salary and $276.7K in other compensation.
Rankings
In 2018, Lloyd Mackenzie's compensation ranked 5,911th out of 14,244 executives tracked by ExecPay. In other words, Mackenzie earned more than 58.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,911 out of 14,244 | 59th |
Division Manufacturing | 2,247 out of 5,759 | 61st |
Major group Chemicals And Allied Products | 837 out of 2,122 | 61st |
Industry group Drugs | 699 out of 1,811 | 61st |
Industry Pharmaceutical Preparations | 543 out of 1,385 | 61st |
Source: SEC filing on October 2, 2019.
Mackenzie's colleagues
We found two more compensation records of executives who worked with Lloyd Mackenzie at Aquinox Pharmaceuticals in 2018.